Atlas Trials

Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease

Clinical trial NCT06978439 · RECRUITING

Trial details

NCT number
NCT06978439
Sponsor
Children's Hospital of Fudan University
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Kawasaki DiseasePilot StudyCoronary Artery AneurysmRivaroxaban
Start date
2024-01-10
Primary completion
2025-12-31
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.